Insmed Inc. shares sunk in late trading Wednesday after the company said its drug to treat a sinus condition failed in a ...

Insmed is discontinuing development of brensocatib in chronic rhinosinusitis without nasal polyps. "Insmed Ends Sinus Drug Development on Failed Study, Acquires Antibody Treatment," at 4:21 p.m. ET, ...

GSK日前宣布，英国药品和健康产品管理局（MHRA）已批准白细胞介素-5（IL-5）靶向抗体疗法Exdensur（depemokimab）用于治疗两项适应症。具体包括作为附加维持疗法，治疗12岁及以上具有2型炎症特征的成人和青少年哮喘患者，这些患者在 ...

Insmed subsequently decided to discontinue the program with immediate effect. ・The company also announced that it has ...

Antrochoanal polyps (ACPs) are benign, solitary lesions that originate from the mucosa of the maxillary sinus and extend into the nasal cavity towards the choana. They can present with unilateral ...

Sinus infections, also known as sinusitis, can leave us feeling miserable with symptoms like nasal congestion, facial pain ...

Nasal polyps are soft, noncancerous growths on the lining of the nose or sinuses. These growths, while painless, can cause blockages that prevent the sinuses from draining properly. This can make it ...

Nasal polyp development, treatment, and recurrence were topics up for discussion in this year’s most popular nasal polyps–related content. Nasal polyp development, treatment, and recurrence, as well ...

1 Add-on maintenance in patients with inadequate response to nasal steroids. 2 Add-on maintenance of chronic rhinosinusitis with nasal polyps (CRSwNP) in patients with inadequate response to nasal ...

Does your nose seem to always be stuffed up? Do you have loss of taste or smell? Do you get frequent sinus infections? If so, you may have nasal polyps. Which raises the question: What exactly are ...